SC
IMGN

Scotia Capital’s Immunogen Inc IMGN Stock Holding History

Scotia Capital’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-19,110
Closed -$567K – 880
2023
Q4 		$567K Buy
19,110
+4,131
+28% +$82.3K ﹤0.01% 559
2023
Q3 		$238K Buy
14,979
+1,769
+13% +$29.4K ﹤0.01% 688
2023
Q2 		$249K Sell
13,210
-3,000
-19% -$35.4K ﹤0.01% 690
2023
Q1 		$62.2K Hold
16,210
– – ﹤0.01% 759
2022
Q4 		$80.4K Hold
16,210
– – ﹤0.01% 748
2022
Q3 		$77K Hold
16,210
– – ﹤0.01% 742
2022
Q2 		$73K Buy
16,210
+34
+0.2% +$148 ﹤0.01% 770
2022
Q1 		$77K Buy
16,176
+356
+2% +$1.97K ﹤0.01% 846
2021
Q4 		$117K Sell
15,820
-5,885
-27% -$36.6K ﹤0.01% 835
2021
Q3 		$123K Sell
21,705
-115
-0.5% -$665 ﹤0.01% 822
2021
Q2 		$144K Hold
21,820
– – ﹤0.01% 790
2021
Q1 		$177K Sell
21,820
-40
-0.2% -$327 ﹤0.01% 752
2020
Q4 		$141K Buy
21,860
+1,582
+8% +$9.23K ﹤0.01% 719
2020
Q3 		$73K Sell
20,278
-2,057
-9% -$8.3K ﹤0.01% 679
2020
Q2 		$104K Buy
22,335
+5,000
+29% +$21.3K ﹤0.01% 598
2020
Q1 		$59K Sell
17,335
-310
-2% -$1.35K ﹤0.01% 612
2019
Q4 		$90K Buy
17,645
+1,080
+7% +$3.67K ﹤0.01% 712
2019
Q3 		$40K Hold
16,565
– – ﹤0.01% 702
2019
Q2 		$36K Hold
16,565
– – ﹤0.01% 712
2019
Q1 		$45K Buy
16,565
+5,000
+43% +$21.7K ﹤0.01% 680
2018
Q4 		$55K Buy
11,565
+700
+6% +$4.25K ﹤0.01% 636
2018
Q3 		$103K Hold
10,865
– – ﹤0.01% 689
2018
Q2 		$113K Hold
10,865
– – ﹤0.01% 643
2018
Q1 		$114K Sell
10,865
-700
-6% -$6.91K ﹤0.01% 673
2017
Q4 		$74K Sell
11,565
-320
-3% -$1.97K ﹤0.01% 693
2017
Q3 		$91K Sell
11,885
-1,700
-13% -$11.3K ﹤0.01% 673
2017
Q2 		$97K Buy
+13,585
New +$62.2K ﹤0.01% 655
2014
Q4 		– Sell
-18,939
Closed -$200K – 622
2014
Q3 		$200K Sell
18,939
-1,100
-5% -$12.4K ﹤0.01% 550
2014
Q2 		$238K Buy
20,039
+439
+2% +$5.51K 0.01% 504
2014
Q1 		$293K Buy
+19,600
New +$309K 0.01% 480

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Scotia Capital's IMGN Position: Q1 2024 in Review

Scotia Capital sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 19,110 shares — an estimated $567K sold.

Scotia Capital first reported a position in IMGN in Q1 2014 and held it in 30 quarters. The position peaked at $567K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Scotia Capital reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Scotia Capital sold 19,110 Immunogen Inc shares in Q1 2024, an estimated $567K.
  • Scotia Capital first reported a position in Immunogen Inc in Q1 2014 and held it in 30 quarters.
  • Scotia Capital's Immunogen Inc position peaked at $567K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Scotia Capital's 13F filing for Q1 2024, filed 14 May 2024.